BOSTON: Christalyn Rhodes, PhD, Founder of StateFair Capital, Inc., a developer of new, AI-powered Environmental, Social, and Governance (ESG) indices designed to beat their benchmarks while building social and health equity, today announced StateFair's first index, the FAIR 100 Health Equity Stock Index, is now listed on Bloomberg (ticker: FAIR) and available for licensing.

As a scientist and entrepreneur, I'm committed to harnessing the power of the best science to solve acute health problems using market-based mechanisms. Powered by a novel algorithm, the Fair 100 Health Equity Index aims to achieve dual objectives profitability and progressive outcomes. The goal is to do well while also doing good - to produce an ROI exceeding index benchmarks through investment that accelerates development of new health care treatments for conditions disproportionately affecting minority communities, such as COVID, asthma, certain cancers, and others, Dr. Rhodes added.

StateFair is a developer of indices composed of publicly-traded companies meeting certain criteria for innovating effective therapies for health conditions that disproportionally affect individuals in minority communities and disadvantaged populations compared to their share of the general population.

The COVID-19 pandemic has exposed health disparities experienced by minority populations, highlighting the urgent need for new treatments and cures for life-threatening conditions more likely to impact Black and Brown people. Bringing together breakthrough science and rigorous analytics, StateFair aims to drive investment that's both profitable and progressive, concluded Dr. Rhodes.

Note Past performance is no guarantee of future results and all investments are subject to loss. For more information, visit http//www.statefaircapital.com/.

StateFair Launches New FAIR 100 Health Equity Stock Index

Liked This Article? Be The First To Share it!

Class

Send